The European Journal of Health Economics

2002 - 2025

Current editor(s): J.-M.G.v.d. Schulenburg

From:
Springer
Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)
Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla (sonal.shukla@springer.com) and Springer Nature Abstracting and Indexing (indexing@springernature.com).

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 10, issue 4, 2009

Ten arguments for a societal perspective in the economic evaluation of medical innovations pp. 357-359

Bengt Jönsson

The socioeconomic costs of mental illness in Spain pp. 361-369

Juan Oliva, Julio López-Bastida, Angel Montejo-González, Ruben Osuna and Beatriz Duque-González

Can Mediterranean diet really influence obesity? Evidence from propensity score matching pp. 371-388

Andreas Drichoutis, Panagiotis Lazaridis and Rodolfo Nayga

Importance of sociodemographic and morbidity aspects in measuring health-related quality of life: performances of three tools pp. 389-397

Cecilia Quercioli, Gabriele Messina, Emanuela Barbini, Giovanni Carriero, Mara Fanì and Nicola Nante

GPs as citizens’ agents: prescription behavior and altruism pp. 399-407

Kim Olsen, Dorte Gyrd-Hansen, Andreas Boegh and Sofie Hansen

Estimating the cost related to surveillance of colorectal cancer in a French population pp. 409-419

Catherine Lejeune, Christine Binquet, Franck Bonnetain, Amel Mahboubi, Michal Abrahamowicz, Thierry Moreau, Maria Raikou, Laurent Bedenne, Catherine Quantin and Claire Bonithon-Kopp

Perceived job security and sickness absence: a study on moral hazard pp. 421-428

Jahangir Khan and Clas Rehnberg

The lack of theoretical support for using person trade-offs in QALY-type models pp. 429-436

Lars Peter Østerdal

Contractual design and PPPs for hospitals: lessons for the Portuguese model pp. 437-453

Pedro Barros and Xavier Martinez-Giralt

Alcohol and labor supply: the case of Iceland pp. 455-465

Tinna Asgeirsdottir and Kerry Anne McGeary

Private expenditure and the role of private health insurance in Greece: status quo and future trends pp. 467-474

Olga Siskou, Daphne Kaitelidou, Charalampos Economou, Peter Kostagiolas and Lycourgos Liaropoulos

Volume 10, issue 3, 2009

Why the econometrician is in good spirits: a workshop through the looking glass pp. 239-242

Carl Hampus Lyttkens

Exploring spatial patterns in general practice expenditure pp. 243-254

Mickael Bech and Jørgen Lauridsen

Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study pp. 255-265

Douglas Taylor, Ankur Pandya, David Thompson, Paula Chu, Jennifer Graff, James Shepherd, Nanette Wenger, Heiner Greten, Rafael Carmena, Michael Drummond and Milton Weinstein

Cost of skin cancer in England pp. 267-273

Stephen Morris, B. Cox and N. Bosanquet

The economic costs of Group B Streptococcus (GBS) disease: prospective cohort study of infants with GBS disease in England pp. 275-285

Elizabeth-Ann Schroeder, Stavros Petrou, Gail Balfour, Oya Edamma and Paul Heath

The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals pp. 287-297

Ansgar Resch, Michael Wilke and Christian Fink

Hybrid risk adjustment for pharmaceutical benefits pp. 299-308

Manuel García-Goñi, Pere Ibern and José Inoriza

Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach pp. 309-321

Bastian Haß, Juliane Lungershausen, Nadine Hertel, Barbara Poulsen Nautrup, Wioletta Kotowa and Hiltrud Liedgens

Material versus social deprivation and health: a case study of an urban area pp. 323-328

Angela Testi and Enrico Ivaldi

Modelling health expenditure at the household level in Greece pp. 329-336

Manos Matsaganis, Theo Mitrakos and Panos Tsakloglou

Total costs of injury from accidents in the home and during education, sports and leisure activities: estimates for Norway with assessment of uncertainty pp. 337-346

Knut Veisten, Åse Nossum and Juned Akhtar

The economics of cochlear implant management in France: a multicentre analysis pp. 347-355

Laurent Molinier, Hélène Bocquet, Vanina Bongard and Bernard Fraysse

Volume 10, issue 2, 2009

Is there a “continental” view of health economics evaluation? pp. 121-123

Claude Pen

Pesticides and farmer health in Nicaragua: a willingness-to-pay approach to evaluation pp. 125-133

Hildegard Garming and Hermann Waibel

The income distributive implications of recent private health insurance policy reforms in Australia pp. 135-148

Alfons Palangkaraya, Jongsay Yong, Elizabeth Webster and Peter Dawkins

International comparison of orthotic brace prices pp. 149-155

Steven Simoens, Paul Guillaume, Ingrid Moldenaers, Antony Depoorter, Sandra Coster, Dirk den Steen, Stefaan Sande, Hans Debruyne, Dirk Ramaekers and Murielle Lona

Guidelines for completing the EURONHEED transferability information checklists pp. 157-165

John Nixon, Stephen Rice, Michael Drummond, Stephanie Boulenger, Philippe Ulmann and Gerard Pouvourville

The labor supply of registered nurses in Finland: the effect of wages and working conditions pp. 167-178

T. Kankaanranta and P. Rissanen

Patient characteristics and fairness pp. 179-186

Hannu Valtonen

Can we assume that research participants are utility maximisers? pp. 187-196

Gethin Griffith, Val Morrison, J. Williams and Rhiannon Edwards

Activity-based funding for National Health Service hospitals in England: managers’ experience and expectations pp. 197-206

Jonathan Sussex and Shelley Farrar

Quality choice in a health care market: a mixed duopoly approach pp. 207-215

Yasuo Sanjo

Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort pp. 217-226

Ulf-G. Gerdtham, L. Andersson, Åsa Ericsson, Sixten Borg, Sven-Arne Jansson, Eva Rönmark and Bo Lundbäck

Factors affecting nurses’ decision to get the flu vaccine pp. 227-231

Shosh Shahrabani, Uri Benzion and Gregory Yom Din

Response to the expertise: Procedures and methods of benefit assessments for medicines in Germany, by Geertruida E. Bekkering and Jos Kleijnen pp. 233-236

Klaus Koch and Stefan Lange

Procedures and methods of benefit assessments for medicines in Germany: give the child a name pp. 237-238

Holger Schünemann, Regina Kunz, Yngve Falck-Ytter and Nancy Santesso

Volume 10, issue 1, 2009

Can we afford to ignore missing data in cost-effectiveness analyses? pp. 1-3

Andrea Marshall, Lucinda Billingham and Stirling Bryan

The burden of colorectal cancer: prevention, treatment and quality of services pp. 1-3

Panos Kanavos and Willemien Schurer

Health care costs, work productivity and activity impairment in non-malignant chronic pain patients pp. 5-13

Christian Kronborg, Gitte Handberg and Flemming Axelsen

Colorectal cancer care in Denmark: status and dilemmas pp. 5-13

Karsten Vrangbaek and Mikkel Nielsen

Colorectal cancer in France pp. 15-20

Karine Chevreul

SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility pp. 15-23

Richard Grieve, Marina Grishchenko and John Cairns

Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer pp. 21-26

Johann Graf von der Schulenburg, Anne Prenzler and Willemien Schurer

Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects pp. 25-38

Christa Claes, Ralf Reinert and Johann-Matthias Schulenburg

Colocteral cancer management and prevention policies in Greece pp. 27-33

Mary Geitona and Panos Kanavos

The disease burden of colorectal cancer in Hungary pp. 35-40

Imre Boncz, Valentin Brodszky, Márta Péntek, István Ágoston, Zsolt Nagy, Krisztián Kárpáti, Ildikó Kriszbacher, Péter Fuszek and László Gulácsi

Comparing methodologies for the cost estimation of hospital services pp. 39-45

S. Tan, F. Rutten, B. Ineveld, W. Redekop and L. Hakkaart- van Roijen

Colorectal cancer in Italy: a review of current national and regional practice on screening and treatment pp. 41-49

Cristina Masseria

Cost utility analysis of knee prosthesis with complete microprocessor control (C-leg) compared with mechanical technology in trans-femoral amputees pp. 47-55

Simone Gerzeli, Aleksandra Torbica and Giovanni Fattore

The status of colorectal cancer care in the Netherlands: past, present and future pp. 51-56

Willemien Schurer

The relationship between the Balanced Budget Act and length of stay for Medicare patients in US hospitals pp. 57-63

Mustafa Younis and Dana Forgione

Colorectal cancer management in Poland: current improvements and future challenges pp. 57-63

Jacek Ruszkowski

Colorectal cancer in Portugal pp. 65-73

Carlos Pinto, Ana Paquete and Irene Pissarra

Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany pp. 65-79

Dirk Schürmann, Sonja Sorensen, Erwin Cock, Sandeep Duttagupta and Ansgar Resch

The challenge of colorectal cancer prevention in Spain pp. 75-83

Julio Lopez-Bastida, Begoña Bellas-Beceiro and Enrique Quintero-Carrión

A comparison between willingness to pay and willingness to give up time pp. 81-91

Debby Helvoort-Postulart, Carmen Dirksen, Alfons Kessels, Jos Engelshoven and M. Myriam Hunink

Colorectal cancer management in the United Kingdom: current practice and challenges pp. 85-90

Willemien Schurer and Panos Kanavos

Colorectal cancer in Russia pp. 91-98

Maria Avksentyeva

The quality of life of Palestinians living in chronic conflict: assessment and determinants pp. 93-101

Awad Mataria, Rita Giacaman, Angelo Stefanini, Nirmala Naidoo, Paul Kowal and Somnath Chatterji

Colorectal cancer in Turkey: current situation and challenges for the future pp. 99-105

Mehtap Tatar and Fahreddin Tatar

Do quality-adjusted life years take account of lost income? Evidence from an Australian survey pp. 103-109

Jeff Richardson, Stuart Peacock and Angelo Iezzi

Colorectal cancer in Mexico: should a middle income country invest in screening or in treatment? pp. 107-114

Emma Verastegui and Alejandro Mohar

An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event pp. 111-119

Manouchehr Tavakoli, Neil Pumford, Mark Woodward, Alex Doney, John Chalmers, Stephen MacMahon and Ronald MacWalter

The dynamics of colorectal cancer management in 17 countries pp. 115-129

Panos Kanavos and Willemien Schurer